Cargando…

Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents

Sirolimus is a hydrophobic macrolide compound that has been used for long-term immunosuppressive therapy, prevention of restenosis, and treatment of lymphangioleiomyomatosis. In this study, a simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and validated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thi-Thao-Linh, Duong, Van-An, Vo, Dang-Khoa, Jo, Jeongae, Maeng, Han-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829871/
https://www.ncbi.nlm.nih.gov/pubmed/33467464
http://dx.doi.org/10.3390/molecules26020425
_version_ 1783641271165779968
author Nguyen, Thi-Thao-Linh
Duong, Van-An
Vo, Dang-Khoa
Jo, Jeongae
Maeng, Han-Joo
author_facet Nguyen, Thi-Thao-Linh
Duong, Van-An
Vo, Dang-Khoa
Jo, Jeongae
Maeng, Han-Joo
author_sort Nguyen, Thi-Thao-Linh
collection PubMed
description Sirolimus is a hydrophobic macrolide compound that has been used for long-term immunosuppressive therapy, prevention of restenosis, and treatment of lymphangioleiomyomatosis. In this study, a simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and validated for the simultaneous determination of sirolimus in both porcine whole blood and lung tissue. Blood and lung tissue homogenates were deproteinized with acetonitrile and injected into the LC-MS/MS system for analysis using the positive electrospray ionization mode. The drug was separated on a C18 reversed phase column with a gradient mobile phase (ammonium formate buffer (5 mM) with 0.1% formic acid and acetonitrile) at 0.2 mL/min. The selected reaction monitoring transitions of m/z 931.5 → 864.4 and m/z 809.5 → 756.5 were applied for sirolimus and ascomycin (the internal standard, IS), respectively. The method was selective and linear over a concentration range of 0.5–50 ng/mL. The method was validated for sensitivity, accuracy, precision, extraction recovery, matrix effect, and stability in porcine whole blood and lung tissue homogenates, and all values were within acceptable ranges. The method was applied to a pharmacokinetic study to quantitate sirolimus levels in porcine blood and its distribution in lung tissue following the application of stents in the porcine coronary arteries. It enabled the quantification of sirolimus concentration until 2 and 14 days in blood and in lung tissue, respectively. This method would be appropriate for both routine porcine pharmacokinetic and bio-distribution studies of sirolimus formulations.
format Online
Article
Text
id pubmed-7829871
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78298712021-01-26 Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents Nguyen, Thi-Thao-Linh Duong, Van-An Vo, Dang-Khoa Jo, Jeongae Maeng, Han-Joo Molecules Article Sirolimus is a hydrophobic macrolide compound that has been used for long-term immunosuppressive therapy, prevention of restenosis, and treatment of lymphangioleiomyomatosis. In this study, a simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and validated for the simultaneous determination of sirolimus in both porcine whole blood and lung tissue. Blood and lung tissue homogenates were deproteinized with acetonitrile and injected into the LC-MS/MS system for analysis using the positive electrospray ionization mode. The drug was separated on a C18 reversed phase column with a gradient mobile phase (ammonium formate buffer (5 mM) with 0.1% formic acid and acetonitrile) at 0.2 mL/min. The selected reaction monitoring transitions of m/z 931.5 → 864.4 and m/z 809.5 → 756.5 were applied for sirolimus and ascomycin (the internal standard, IS), respectively. The method was selective and linear over a concentration range of 0.5–50 ng/mL. The method was validated for sensitivity, accuracy, precision, extraction recovery, matrix effect, and stability in porcine whole blood and lung tissue homogenates, and all values were within acceptable ranges. The method was applied to a pharmacokinetic study to quantitate sirolimus levels in porcine blood and its distribution in lung tissue following the application of stents in the porcine coronary arteries. It enabled the quantification of sirolimus concentration until 2 and 14 days in blood and in lung tissue, respectively. This method would be appropriate for both routine porcine pharmacokinetic and bio-distribution studies of sirolimus formulations. MDPI 2021-01-15 /pmc/articles/PMC7829871/ /pubmed/33467464 http://dx.doi.org/10.3390/molecules26020425 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nguyen, Thi-Thao-Linh
Duong, Van-An
Vo, Dang-Khoa
Jo, Jeongae
Maeng, Han-Joo
Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents
title Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents
title_full Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents
title_fullStr Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents
title_full_unstemmed Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents
title_short Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents
title_sort development and validation of a bioanalytical lc-ms/ms method for simultaneous determination of sirolimus in porcine whole blood and lung tissue and pharmacokinetic application with coronary stents
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829871/
https://www.ncbi.nlm.nih.gov/pubmed/33467464
http://dx.doi.org/10.3390/molecules26020425
work_keys_str_mv AT nguyenthithaolinh developmentandvalidationofabioanalyticallcmsmsmethodforsimultaneousdeterminationofsirolimusinporcinewholebloodandlungtissueandpharmacokineticapplicationwithcoronarystents
AT duongvanan developmentandvalidationofabioanalyticallcmsmsmethodforsimultaneousdeterminationofsirolimusinporcinewholebloodandlungtissueandpharmacokineticapplicationwithcoronarystents
AT vodangkhoa developmentandvalidationofabioanalyticallcmsmsmethodforsimultaneousdeterminationofsirolimusinporcinewholebloodandlungtissueandpharmacokineticapplicationwithcoronarystents
AT jojeongae developmentandvalidationofabioanalyticallcmsmsmethodforsimultaneousdeterminationofsirolimusinporcinewholebloodandlungtissueandpharmacokineticapplicationwithcoronarystents
AT maenghanjoo developmentandvalidationofabioanalyticallcmsmsmethodforsimultaneousdeterminationofsirolimusinporcinewholebloodandlungtissueandpharmacokineticapplicationwithcoronarystents